Katadolon



Indications and Reactions:

Role Indications Reactions
Secondary
Back Pain 17.2%
Drug Use For Unknown Indication 12.9%
Pain 8.6%
Product Used For Unknown Indication 6.0%
Bone Pain 5.2%
Breast Cancer Metastatic 5.2%
Type 2 Diabetes Mellitus 5.2%
Rheumatic Disorder 4.3%
Analgesic Therapy 3.4%
Anxiety Disorder 3.4%
Arthropathy 3.4%
Dyspepsia 3.4%
Hypercholesterolaemia 3.4%
Osteoarthritis 3.4%
Depression 2.6%
Erectile Dysfunction 2.6%
Hypertension 2.6%
Nausea 2.6%
Psoriatic Arthropathy 2.6%
Epilepsy 1.7%
Weight Decreased 14.6%
Hepatic Enzyme Increased 9.8%
Rash 7.3%
Deafness 4.9%
Hepatotoxicity 4.9%
Liver Function Test Abnormal 4.9%
Liver Injury 4.9%
Neoplasm Progression 4.9%
Pregnancy 4.9%
Pulmonary Hypertension 4.9%
Somnolence 4.9%
Suicide Attempt 4.9%
Umbilical Hernia 4.9%
Vomiting 4.9%
Circulatory Collapse 2.4%
Hepatitis 2.4%
Nasopharyngitis 2.4%
Nausea 2.4%
Tachycardia 2.4%
Thrombin Time Prolonged 2.4%
Concomitant
Drug Use For Unknown Indication 20.8%
Rheumatoid Arthritis 13.4%
Hypertension 10.4%
Product Used For Unknown Indication 9.7%
Pain 9.4%
Osteoporosis 8.4%
Back Pain 4.4%
Depression 4.4%
Prostate Cancer 4.0%
Diarrhoea 2.0%
Multiple Sclerosis 2.0%
Leukocytosis 1.7%
Neuralgia 1.7%
Migraine 1.3%
Renal Transplant 1.3%
Bladder Dysfunction 1.0%
Bone Disorder 1.0%
Breast Cancer 1.0%
Colon Cancer Metastatic 1.0%
Contraception 1.0%
Tooth Loss 8.9%
Hepatitis Acute 7.1%
Epilepsy 5.4%
Gastrointestinal Haemorrhage 5.4%
Liver Function Test Abnormal 5.4%
Pain 5.4%
Pneumonia 5.4%
Renal Failure Acute 5.4%
Sepsis 5.4%
Squamous Cell Carcinoma 5.4%
Suicide Attempt 5.4%
Syncope 5.4%
Vertigo Positional 5.4%
Anaemia 3.6%
Autoimmune Thrombocytopenia 3.6%
Electrocardiogram Qt Prolonged 3.6%
Haematoma 3.6%
Hepatitis 3.6%
Hypercalcaemia 3.6%
Hypersensitivity 3.6%
Interacting
Product Used For Unknown Indication 50.0%
Pain 30.0%
Thrombosis Prophylaxis 20.0%
Hepatitis Acute 75.0%
Rhabdomyolysis 25.0%